CW February 2001
Volume 10Issue Number 2 February 2001 ISSN 10593802 First Injectable COX-2 Inhibitor: An Effective Alternative in Pain ManagementParecoxib, the first injectable COX-2 inhibitor is currently being studied in clinical trials. While oral COX-2 inhibitors treat chronic pain and inflammation without unwanted side effects, their onset is too slow for post-surgical use. If approved, injectable parecoxib may provide physicians with an alternative mode of treating acute, post-surgical pain.
Go to Previous Page Go to Next Page Source & Additional Reading 19th Annual Scientific Meeting of the American Pain Society. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW February 2001Purchase Downloadable Full-text PDF of Complete Issue: $10.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
